Genentech alum Jane Grogan goes startup hopping from ArsenalBio to Graphite Bio; Scott Holmes to handle CFO duties at Catamaran Bio, teaming up again with ex-Disarm CEO

Jane Grogan

→ Gene editing player Graphite Bio notched a $150 million Series B megaround to boost its total to $195 million, and a month later, Jane Grogan is moving from another startup to be Graphite’s CSO. Grogan is leaving ArsenalBio...

Click to view original post